Electroacupoint for Diminutive Milk Production
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-30
SponsorHaytham Ibrahim Morsi
About this trial
The purpose of this study was to reveal the effect of electroacupoint on scanty milk production in lactating women.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
They were complaining of insufficiency of lactation within the first month after cesarean section.
They are using mixed feeding; both breast and bottle feeding, between three and six bottles per day.
Their age ranged from 25-30 years old.
Their body mass index didn't exceeded 30 kg/m2.
Disqualifiers
Postpartum haemorrhage.
Cardiorespiratory disease.
Diabetes mellitus.
Breast cancer.
Trial design
Design model
Parallel
Treatments tested in this trial
Electrotherapy using Chattanooga stimulation unit
Procedure/SurgeryElectroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit 2783. It uses the influences energy flows by needling the acupuncture points which lie along the body meridians to achieve a harmonious balance between physical, emotional, and spiritual states. The same effect can be achieved without the use of needles. These needleless stimulations are noninvasive and nontraumatic and are useful for individuals who are scared of needles. They are also associated with decreased risk of infection or bruise.
Balanced Diet using domperidone drug, iron, and folic acid supplementation.
Dietary supplementPostnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care. It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.
Treatment groups
36 Participants
are divided into 2 treatment groupsGroup A: Electroacupoint combined with postnatal careExperimental treatment 2 interventions
Group B: postnatal care onlyActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change in Baby Weight.
Measurement of Baby Weight using the Baby Weight Scale.
Time frame
Change from Baseline Baby Weight at three months.2
Change in Serum Prolactin Level.
Measurement of Serum Prolactin Level using the Serum Blood Test.
Time frame
Change from Baseline Serum Prolactin Level at three months.3
Change in Flow of Milk.
Measurement of Flow of Milk using the Visual Analogue Scale.
Time frame
Change from Baseline Flow of Milk at three months.Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Kafrelsheikh UniversityRecruiting Kafrelsheikh
Egypt
EgyptSponsors and contacts
Click on the lead sponsor to view all of their trials.
Haytham Ibrahim Morsi
Lead sponsor
Kafrelsheikh University
Sponsor institution
Source ClinicalTrials.gov